(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Brooge Energy Limited , Bionano Genomics, and Golden Bull Limited.

The three biggest losers today are Creative Realities, Amerco, and Tilray.

Winners today

1. Brooge Energy Limited (BROGW) – 27.2%

NASDAQ ended the session with Brooge Energy Limited rising 27.2% to $0.07 on Wednesday, after five sequential sessions in a row of losses. NASDAQ slid 0.63% to $12,935.29, after three sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

More news about Brooge Energy Limited .

2. Bionano Genomics (BNGOW) – 25%

NASDAQ ended the session with Bionano Genomics rising 25% to $0.05 on Wednesday, after five sequential sessions in a row of losses. NASDAQ fell 0.63% to $12,935.29, after three sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

Yearly Top and Bottom Value

Bionano Genomics’s stock is valued at $0.05 at 17:32 EST, below its 52-week low of $0.05.

More news about Bionano Genomics.

3. Golden Bull Limited (BTBT) – 18.05%

Bit Digital, Inc., together with its subsidiaries, engages in the bitcoin mining business. It is also involved in the treasury management activities; and digital asset staking and digital asset mining businesses, as well as ethereum staking activities. The company was formerly known as Golden Bull Limited and changed its name to Bit Digital, Inc. in September 2020. Bit Digital, Inc. was founded in 2015 and is headquartered in New York, New York.

NASDAQ ended the session with Golden Bull Limited rising 18.05% to $3.27 on Wednesday, after two consecutive sessions in a row of gains. NASDAQ fell 0.63% to $12,935.29, after three consecutive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Golden Bull Limited has a trailing twelve months EPS of $-1.49.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -82.48%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Golden Bull Limited’s EBITDA is -3.39.

Revenue Growth

Year-on-year quarterly revenue growth declined by 41.9%, now sitting on 32.3M for the twelve trailing months.

More news about Golden Bull Limited.

4. Aspen Group (ASPU) – 17.02%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group jumping 17.02% to $0.17 on Wednesday while NASDAQ dropped 0.63% to $12,935.29.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.33.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aspen Group’s stock is considered to be overbought (>=80).

Sales Growth

Aspen Group’s sales growth is negative 24% for the present quarter and negative 29.3% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Aspen Group’s EBITDA is 342.31.

Yearly Top and Bottom Value

Aspen Group’s stock is valued at $0.17 at 17:32 EST, way below its 52-week high of $1.34 and way above its 52-week low of $0.03.

More news about Aspen Group.

5. Brilliant Acquisition Corporation (BRLIR) – 11.06%

NASDAQ ended the session with Brilliant Acquisition Corporation rising 11.06% to $0.18 on Wednesday, after five successive sessions in a row of losses. NASDAQ fell 0.63% to $12,935.29, after three successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Yearly Top and Bottom Value

Brilliant Acquisition Corporation’s stock is valued at $0.18 at 17:32 EST, above its 52-week high of $0.18.

More news about Brilliant Acquisition Corporation.

6. Cemtrex (CETXP) – 10.83%

Cemtrex, Inc. operates as a technology company in the United States and internationally. The company operates through Advanced Technologies and Industrial Services segments. The Advanced Technologies segment provides Internet of Things products and smart devices under the SmartDesk name for mobile, web, virtual and augmented reality, wearables, and television markets; and security and video surveillance solutions, and virtual and augmented reality solutions for various commercial and industrial applications. This segment also offers browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. The Industrial Services segment provides single-source services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly; installs high precision equipment in various industrial markets comprising automotive, printing and graphics, industrial automation, packaging, chemicals and others; and provides maintenance and contracting solutions for the machinery, packaging, printing, chemical, and other manufacturing markets. The company was formerly known as Diversified American Holding, Inc. and changed its name to Cemtrex, Inc. in December 2004. Cemtrex, Inc. was incorporated in 1998 and is headquartered in Brooklyn, New York.

NASDAQ ended the session with Cemtrex rising 10.83% to $0.66 on Wednesday while NASDAQ fell 0.63% to $12,935.29.

Earnings Per Share

As for profitability, Cemtrex has a trailing twelve months EPS of $-0.825.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -69.1%.

Yearly Top and Bottom Value

Cemtrex’s stock is valued at $0.66 at 17:32 EST, way below its 52-week high of $1.61 and way above its 52-week low of $0.22.

Volume

Today’s last reported volume for Cemtrex is 521 which is 96.17% below its average volume of 13606.

Moving Average

Cemtrex’s worth is way higher than its 50-day moving average of $0.55 and above its 200-day moving average of $0.62.

Revenue Growth

Year-on-year quarterly revenue growth grew by 36.8%, now sitting on 57.16M for the twelve trailing months.

More news about Cemtrex.

7. Calyxt (CLXT) – 9.55%

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.

NASDAQ ended the session with Calyxt jumping 9.55% to $6.54 on Wednesday while NASDAQ fell 0.63% to $12,935.29.

Earnings Per Share

As for profitability, Calyxt has a trailing twelve months EPS of $-3.83.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -189.52%.

Volume

Today’s last reported volume for Calyxt is 88227 which is 1057.53% above its average volume of 7622.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Calyxt’s EBITDA is 154.69.

More news about Calyxt.

8. Zai Lab (ZLAB) – 9.36%

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Its commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. The company also develops Odronextamab to treat follicular lymphoma, diffuse large B-cell lymphoma, and other B-celllymphomas; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Margetuximab for the treatment of breast and gastroesophageal cancers; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, pancreatic cancer, and other solid tumors; and Bemarituzumab to treat gastric and gastroesophageal junction cancer. In addition, it develops Zipalertinib for the treatment of patients with EGFR exon 20 insertion NSCLC; Elzovantinib, an orally bioavailable multi-targeted kinase inhibitor; ZL-2313, an investigational oral EGFR inhibitor; ZL-1211, a humanized IgG1 monoclonal antibody that targets CLDN18.2; ZL-1218 is humanized IgG1 monoclonal antibody to induce potent antibody-dependent cellular cytotoxicity activity that enables NK cell-mediated killing of CCR8-expressing T-regs; Efgartigimod to reduce disease-causing immunoglobulin G antibodies; ZL-1102, a human nanobody targeting interleukin- 17A; Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter; and KarXT for the treatment of psychiatric and neurological conditions. The company was incorporated in 2013 and is headquartered in Shanghai, China.

NASDAQ ended the session with Zai Lab rising 9.36% to $33.66 on Wednesday, following the last session’s downward trend. NASDAQ fell 0.63% to $12,935.29, after three successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Zai Lab has a trailing twelve months EPS of $-3.82.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.51%.

Volatility

Zai Lab’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.23%, a negative 0.63%, and a positive 3.53%.

Zai Lab’s highest amplitude of average volatility was 3.49% (last week), 3.71% (last month), and 3.53% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 50.7% and 57.1%, respectively.

Yearly Top and Bottom Value

Zai Lab’s stock is valued at $33.66 at 17:32 EST, way below its 52-week high of $53.95 and way higher than its 52-week low of $20.98.

More news about Zai Lab.

9. Cabaletta Bio (CABA) – 8.98%

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; CABA-201, a 4-1BB-containing CD19-CAR T investigational therapy, for the treatment of severe autoimmune diseases; PLA2R-CAART, a discovery stage product to treat patients with PLA2R-associated membranous nephropathy; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

NASDAQ ended the session with Cabaletta Bio rising 8.98% to $9.83 on Wednesday while NASDAQ fell 0.63% to $12,935.29.

Earnings Per Share

As for profitability, Cabaletta Bio has a trailing twelve months EPS of $-1.58.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.34%.

Moving Average

Cabaletta Bio’s value is higher than its 50-day moving average of $9.56 and way above its 200-day moving average of $6.25.

More news about Cabaletta Bio.

10. CureVac N.V. (CVAC) – 8.79%

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer therapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

NASDAQ ended the session with CureVac N.V. rising 8.79% to $9.65 on Wednesday, after four successive sessions in a row of losses. NASDAQ fell 0.63% to $12,935.29, after three consecutive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, CureVac N.V. has a trailing twelve months EPS of $-1.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.77%.

More news about CureVac N.V..

Losers Today

1. Creative Realities (CREXW) – -19%

NASDAQ ended the session with Creative Realities falling 19% to $0.01 on Wednesday, after five consecutive sessions in a row of losses. NASDAQ fell 0.63% to $12,935.29, after three sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

Yearly Top and Bottom Value

Creative Realities’s stock is valued at $0.01 at 17:32 EST, way above its 52-week high of $0.01.

More news about Creative Realities.

2. Amerco (UHAL) – -14.18%

U-Haul Holding Company operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada. The company's Moving and Storage segment rents trucks, trailers, portable moving and storage units, specialty rental items, and self-storage spaces primarily to the household movers; and sells moving supplies, towing accessories, and propane. It also provides uhaul.com, an online marketplace that connects consumers to independent Moving Help service providers and independent self-storage affiliates; auto transport and tow dolly options to transport vehicles; and specialty boxes for dishes, computers, flat screen television, and sensitive electronic equipment, as well as tapes, security locks, and packing supplies. This segment rents its products and services through a network of approximately 2,100 company operated retail moving stores and 21,100 independent U-Haul dealers. As of March 31, 2022, it had a rental fleet of approximately 186,000 trucks, 128,000 trailers, and 46,000 towing devices; and 1,844 self-storage locations with approximately 876,000 rentable storage units. The company's Property and Casualty Insurance segment offers loss adjusting and claims handling services. It also provides moving and storage protection packages, such as Safemove and Safetow packages, which offer moving and towing customers with a damage waiver, cargo protection, and medical and life insurance coverage; Safestor that protects storage customers from loss on their goods in storage; Safestor Mobile, which protects customers stored belongings; and Safemove Plus, which provides rental customers with a layer of primary liability protection. The company's Life Insurance segment provides life and health insurance products primarily to the senior market through the direct writing and reinsuring of life insurance, medicare supplement, and annuity policies. The company was formerly known as AMERCO. U-Haul Holding Company was founded in 1945 and is based in Reno, Nevada.

NASDAQ ended the session with Amerco falling 14.18% to $54.06 on Wednesday, following the last session’s downward trend. NASDAQ fell 0.63% to $12,935.29, after three consecutive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Amerco has a trailing twelve months EPS of $4.45.

PE Ratio

Amerco has a trailing twelve months price to earnings ratio of 12.15. Meaning, the purchaser of the share is investing $12.15 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.9%.

More news about Amerco.

3. Tilray (TLRY) – -9.02%

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.

NASDAQ ended the session with Tilray sliding 9.02% to $1.67 on Wednesday, after five sequential sessions in a row of losses. NASDAQ dropped 0.63% to $12,935.29, after three sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Tilray has a trailing twelve months EPS of $-2.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.15%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Tilray’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

Tilray’s stock is valued at $1.67 at 17:32 EST, way below its 52-week low of $2.17.

Moving Average

Tilray’s value is way under its 50-day moving average of $2.50 and way under its 200-day moving average of $3.16.

More news about Tilray.

4. Marvell Technology Group (MRVL) – -7.1%

Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions, spanning the data center core to network edge. The company develops, scales complex System-on-a-Chip architectures, integrating analog, mixed-signal, and digital signal processing functionality. It offers a portfolio of Ethernet solutions, including controllers, network adapters, physical transceivers, and switches; single or multiple core processors; custom application specific integrated circuits; and System-on-a-Chip solutions. The company also provides electro-optical products, including pulse amplitude modulations, coherent digital signal processors, laser drivers, trans-impedance amplifiers, silicon photonics, and data center interconnect solutions; fibre channel products comprising host bus adapters and controllers; single or multiple core processors; storage controllers for hard disk drives and solid-state-drives; and host system interfaces, including serial attached SCSI, serial advanced technology attachment, peripheral component interconnect express, non-volatile memory express (NVMe), and NVMe over fabrics. It has operations in the United States, Argentina, China, India, Israel, Japan, Singapore, South Korea, Taiwan, and Vietnam. Marvell Technology, Inc. was incorporated in 1995 and is headquartered in Wilmington, Delaware.

NASDAQ ended the session with Marvell Technology Group falling 7.1% to $58.90 on Wednesday while NASDAQ slid 0.63% to $12,935.29.

Earnings Per Share

As for profitability, Marvell Technology Group has a trailing twelve months EPS of $-0.19.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.08%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marvell Technology Group’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 45.6% and a negative 31.6%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 8.7%, now sitting on 5.79B for the twelve trailing months.

More news about Marvell Technology Group.

5. Brookfield Residential Properties (BRP) – -6.56%

BRP Group, Inc. markets and sells insurance products and services in the United States. It operates through four segments: Middle Market, Specialty, MainStreet, and Medicare. The Middle Market segment provides commercial risk management, employee benefits solutions, and private risk management for mid-to-large size businesses and high net worth individuals, as well as its families. The Specialty segment delivers specialty insurers, professionals, individuals, and industry businesses the access to specialty markets, as well as capabilities and programs requiring underwriting and placement; and operates as a managing general agent of the Future platform, which delivers proprietary, technology-enabled insurance solutions. The MainStreet segment offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in its communities. The Medicare segment provides consultation for government assistance programs and solutions, including Medicare and Medicare Advantage to seniors and Medicare-eligible individuals through a network of primarily independent contractor agents. The company was founded in 2011 and is headquartered in Tampa, Florida.

NASDAQ ended the session with Brookfield Residential Properties falling 6.56% to $19.79 on Wednesday, following the last session’s downward trend. NASDAQ fell 0.63% to $12,935.29, after three sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Brookfield Residential Properties has a trailing twelve months EPS of $-1.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.46%.

Yearly Top and Bottom Value

Brookfield Residential Properties’s stock is valued at $19.79 at 17:32 EST, way under its 52-week high of $33.34 and above its 52-week low of $19.76.

Revenue Growth

Year-on-year quarterly revenue growth grew by 36.1%, now sitting on 1.07B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Brookfield Residential Properties’s EBITDA is 2.59.

More news about Brookfield Residential Properties.

6. Niu Technologies (NIU) – -6.42%

Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers RQi, NQi, MQi, SQi, UQi, and Gova series electric scooters and motorcycles; KQi series one kick-scooters; BQi series e-bikes; and Niu Aero Sports Bicycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, smart check, and smart services, as well as NIU cover, which provides insurance services. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Niu Technologies dropping 6.42% to $3.43 on Wednesday, after five sequential sessions in a row of losses. NASDAQ slid 0.63% to $12,935.29, after three successive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Niu Technologies has a trailing twelve months EPS of $-0.14.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.41%.

Volatility

Niu Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.07%, a positive 0.02%, and a positive 3.03%.

Niu Technologies’s highest amplitude of average volatility was 4.07% (last week), 4.06% (last month), and 3.03% (last quarter).

Yearly Top and Bottom Value

Niu Technologies’s stock is valued at $3.43 at 17:32 EST, way below its 52-week high of $9.60 and way above its 52-week low of $2.57.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Niu Technologies’s EBITDA is 0.09.

Volume

Today’s last reported volume for Niu Technologies is 417283 which is 20.44% below its average volume of 524498.

More news about Niu Technologies.

7. Bilibili (BILI) – -6.34%

Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. Its platform offers a range of content, including video services, mobile games, and value-added service, as well as ACG-related comic and audio content. The company's video services include professional user generated videos, occupationally generated videos, live broadcasting, and story mode. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.

NASDAQ ended the session with Bilibili falling 6.34% to $15.52 on Wednesday, following the last session’s downward trend. NASDAQ slid 0.63% to $12,935.29, after three successive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Bilibili has a trailing twelve months EPS of $-2.63.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.63%.

More news about Bilibili.

8. Prudential Public Limited Company (PUK) – -6.08%

Prudential plc, through its subsidiaries, provides life and health insurance, and retirement and asset management solutions to individuals in Asia, and Africa. It offers health and protection, as well as non- participating savings products, such as protection and investment-linked products. The company also provides insurance against common critical illnesses; property and casualty; and tropical disease protection, such as dengue, malaria, and measles. The company was founded in 1848 and is headquartered in London, the United Kingdom.

NYSE ended the session with Prudential Public Limited Company dropping 6.08% to $26.43 on Wednesday, after three sequential sessions in a row of gains. NYSE fell 0.72% to $14,887.14, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Prudential Public Limited Company has a trailing twelve months EPS of $0.73.

PE Ratio

Prudential Public Limited Company has a trailing twelve months price to earnings ratio of 36.21. Meaning, the purchaser of the share is investing $36.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.86%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Prudential Public Limited Company’s stock is considered to be oversold (<=20).

Volatility

Prudential Public Limited Company’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.04%, a negative 0.47%, and a positive 1.86%.

Prudential Public Limited Company’s highest amplitude of average volatility was 1.04% (last week), 1.72% (last month), and 1.86% (last quarter).

Volume

Today’s last reported volume for Prudential Public Limited Company is 592336 which is 6.72% above its average volume of 554988.

Yearly Top and Bottom Value

Prudential Public Limited Company’s stock is valued at $26.43 at 17:32 EST, way under its 52-week high of $34.37 and way above its 52-week low of $18.20.

More news about Prudential Public Limited Company.

9. Freshpet (FRPT) – -5.9%

Freshpet, Inc. manufactures and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe. The company sells its products under the Freshpet brand; and Dognation and Dog Joy labels through various classes of retail, including grocery, mass, club, pet specialty, and natural, as well as online. Freshpet, Inc. was incorporated in 2004 and is headquartered in Secaucus, New Jersey.

NASDAQ ended the session with Freshpet sliding 5.9% to $59.63 on Wednesday while NASDAQ fell 0.63% to $12,935.29.

Earnings Per Share

As for profitability, Freshpet has a trailing twelve months EPS of $-1.39.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.06%.

Yearly Top and Bottom Value

Freshpet’s stock is valued at $59.63 at 17:32 EST, way under its 52-week high of $73.48 and way above its 52-week low of $36.02.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 4.4% and 64.1%, respectively.

Previous days news about Freshpet

• : freshpet says activist jana partners made ‘unfounded’ claims. According to MarketWatch on Tuesday, 30 May, "Freshpet said Jana made "several erroneous and unfounded claims" about the board and omitted information "critical to understanding the intent and effect of the board’s actions." Jana, Freshpet’s biggest shareholder, is readying a proxy fight with Freshpet to nominate its own directors to serve on the company’s board and sent a letter to the company last week.", "On Tuesday, Freshpet said that its board "has acted in the best interests of all stockholders, in accordance with the directors’ fiduciary duties, and in compliance" with the company’s charter."

More news about Freshpet.

10. Genworth Financial (GNW) – -5.82%

Genworth Financial, Inc. provides insurance products in the United States and internationally. It operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S. Life Insurance segment offers long-term care insurance products; and service traditional life insurance and fixed annuity products in the United States. The Runoff segment includes variable annuity, variable life insurance, and corporate-owned life insurance, as well as funding agreements. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.

NYSE ended the session with Genworth Financial sliding 5.82% to $5.33 on Wednesday, following the last session’s downward trend. NYSE dropped 0.72% to $14,887.14, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Genworth Financial has a trailing twelve months EPS of $0.94.

PE Ratio

Genworth Financial has a trailing twelve months price to earnings ratio of 5.67. Meaning, the purchaser of the share is investing $5.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.22%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Genworth Financial’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 2.1%, now sitting on 7.47B for the twelve trailing months.

Moving Average

Genworth Financial’s value is below its 50-day moving average of $5.43 and above its 200-day moving average of $5.02.

More news about Genworth Financial.

Stay up to date with our winners and losers daily report